3105-LB: Modeling the Long-Term Consequences of GDM
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-3105-lb ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von DEVI KASINATHAN und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Women with gestational diabetes (GDM) are at elevated risk of type 2 diabetes and cardiovascular disease, but the contributing mechanisms remain unknown. While GDM models exist, long-term consequences remain unexplored. We selected a model in which FoxM1 is deleted in beta cells (Foxm1Δβ mice), representing the substantial minority of GDM driven by β-cell failure, to address this gap.
Methods
We assessed glycemic status by GTTs, ITTs, and fasting insulin, β-cell mass by morphology, and β-cell RNA expression was analyzed by RNAseq with immunolabeling confirmation. Heart damage markers were assessed by qPCR (e.g. Nppa, Tgfb, and Acta).
Results
Young female Foxm1Δβ mice exhibit β-cell mass reductions of ~60% compared to controls and maintain low β-cell mass during pregnancy. They display normoglycemia except during pregnancy, when they show impaired glucose tolerance, fulfilling GDM criteria. Both parous and non-parous Foxm1Δβ mice develop type 2 diabetes by 12 months of age accompanied by low serum insulin. Strikingly, non-parous Foxm1Δβ mice develop diabetes by just 6 months of age. scRNAseq revealed increased β-cell ER and mitochondrial stress in both parous and non-parous Foxm1Δβ mice compared to their respective heterozygous controls. However, few differentially expressed genes (<25) distinguished parous from non-parous Foxm1Δβ mice. The accelerated diabetes onset in non-parous Foxm1Δβ mice may be explained by a difference in β-cell mass: compared to controls, β-cell mass was ~10% in non-parous versus ~70% in parous Foxm1Δβ mice. Although parous and non-parous controls showed no glycemic differences, parous controls had elevated mitochondrial stress markers. Importantly, we observed elevated heart damage markers in parous Foxm1Δβ mice.
Conclusion
We demonstrate that pregnancy may protect β cells despite GDM-associated hyperglycemia. In contrast, hyperglycemic insults during pregnancy may cause lasting cardiovascular damage. Together, our findings provide the first model for studying the major long-term consequences of GDM. Disclosure D. Kasinathan: Research Support; Current; Islex Therapeutics. J. Lee: None. Y. Wang: None. S.F. Kim: None. M. Golson: Research Support; Current; Islex Therapeutics. Funding American Diabetes Association (7-23-IBSWH-05)
Zitieren
APA
KASINATHAN, D., LEE, J., WANG, Y. J., KIM, S. F., & GOLSON, M. (2026). 3105-LB: Modeling the Long-Term Consequences of GDM. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-3105-lb
Vancouver
KASINATHAN D, LEE J, WANG YJ, KIM SF, GOLSON M. 3105-LB: Modeling the Long-Term Consequences of GDM. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-3105-lb
BibTeX
@article{KASINATHAN2026,
author = {KASINATHAN, DEVI and LEE, JIHYUN and WANG, YUE JULIA and KIM, SANGWON F. and GOLSON, MARIA},
title = {3105-LB: Modeling the Long-Term Consequences of GDM},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-3105-lb}
}
EUVIMED